Second neoplasms in pediatric patients treated for cancer: A center's 30-year experience

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 6, 2006, Pages 374-378

  Çaǧlar, Kudret ^a,b   Varan, Ali ^a   Akyüz, Canan ^a   Selek, Ugur ^a   Kutluk, Tezer ^a   Yalçn, Bilgehan ^a   Lale Atahan, I ^a   Buyukpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Hacettepe University ^*  (Turkey)

Author keywords

Cancer; Children; Second neoplasms; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ARTICLE; ASTROCYTOMA; CHILD; CHILDHOOD CANCER; EPENDYMOMA; EWING SARCOMA; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NASOPHARYNX CARCINOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RETINOBLASTOMA; RHABDOMYOSARCOMA; SECOND CANCER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33745637285     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/00043426-200606000-00010     Document Type: Article

References (38)

1. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer. 2002;2:124-132.
2. de Vathaire F, Hawkins M, Campbell S, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999;79:1884-1893.
3. Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer. 2003;97:2588-2596.
4. Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer. 2003;89:1638-1644.
5. Gow KW, Lensing S, Hill DA, et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg. 2003;38:1574-1580.
6. Vazquez E, Castellote A, Piqueras J, et al. Second malignancies in pediatric patients: imaging findings and differential diagnosis. Radiographics. 2003;23:1155-1172.
7. Smith MB, Xue H, Strong L, et al. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg. 1993;28:1342-1348.
8. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-239.
9. Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am. 1993;7:401-415.
10. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629.
11. Kowalczyk JR, Nurzynska J, Armata J, et al. International note: second malignant neoplasms in children: a multicenter study of the Polish Pediatric Leukemia/Lymphoma Group. Med Pediatr Oncol. 2002;38:421-423.
12. Leung W, Sandlund JT, Hudson MM, et al. Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer. 2001;92:1959-1966.
13. Davies SM. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol. 2001;36:536-540.
14. Löning L, Zimmermann M, Reiter A, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 2000;95:2770-2775.
15. Rich DC, Corpron CA, Smith MB, et al. Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg. 1997;32:369-372.
16. Perentesis JP. Genetic predisposition and treatment-related leukemia. Med Pediatr Oncol. 2001;36:541-548.
17. Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol. 2001;36:525-535.
18. Shore RE. Radiation-induced skin cancer in humans. Med Pediatr Oncol. 2001;36:549-554.
19. Epstein E Jr. Genetic determinants of basal cell carcinoma risk. Med Pediatr Oncol. 2001;36:555-558.
20. Rosso P, Terracini B, Fears TR, et al. Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy. Int J Cancer. 1994;59:451-456.
21. Humpl T, Fritsche M, Bartels U, et al. Survivors of childhood cancer for more than twenty years. Acta Oncol. 2001;40:44-49.
22. Neglia JP. Childhood cancer survivors. Past, present, and future. Cancer. 1994;73:2883-2885.
23. Travis LB. Therapy-associated solid tumors. Acta Oncol. 2002;41:323-333.
24. Hildebrand J, Malarme M, Flament-Durand J, et al. Acute nonlymphoblastic leukemia in a patient treated for brain tumor. Arch Neurol. 1982;39:664-665.
25. Casteels K, Renard M, Van Gool S, et al. Secondary acute lymphoblastic leukemia in a child three years after treatment for medulloblastoma. Med Pediatr Oncol. 2001;36:390-391.
26. Kaste SC, Hudson MM, Jones DJ, et al. Breast masses in women treated for childhood cancer: incidence and screening guidelines. Cancer. 1998;82:784-792.
27. Boice JD Jr. Radiation and breast carcinogenesis. Med Pediatr Oncol. 2001;36:508-513.
28. Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol. 2001;36:568-573.
29. Rabes HM. Gene rearrangements in radiation-induced thyroid carcinogenesis. Med Pediatr Oncol. 2001;36:574-582.
30. Garaventa A, Haupt R, Panarello C, et al. Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease. Med Pediatr Oncol. 2001;36:396-397.
31. Imashuku S, Hibi S, Kosaka K, et al. Secondary lymphoid malignancy in two children with neuroblastoma. Med Pediatr Oncol. 1996;27:54-56.
32. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.
33. Wenzel CT, Halperin EC, Fisher SR. Second malignant neoplasms of the head and neck in survivors of retinoblastoma. Ear Nose Throat J. 2001;80:108-112.
34. Nahum MP, Gdal-On M, Kuten A, et al. Long-term follow-up of children with retinoblastoma. Pediatr Hematol Oncol. 2001;18:173-179.
35. Ragusa R, Russo S, Villari L, et al. Hodgkin's disease as a second malignant neoplasm in childhood: report of a case and review of the literature. Pediatr Hematol Oncol. 2001;18:407-414.
36. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996;14:2815-2825.
37. Rubino C, Shamsaldin A, Le MG, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat. 2005;89:277-288.
38. Hall EJ, Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationship for carcinogenesis. Int J Radiat Biol. 2004;80:327-337.